Jazz Pharmaceuticals Alternatives & Competitors
12 companies similar to Jazz Pharmaceuticals — Identifying, developing and commercializing meaningful products that address unm...
Companies similar to Jazz Pharmaceuticals
Ultragenyx
Going Beyond Every Day
Novato, United States
RELIEF THERAPEUTICS Holding SA
Providing relief to patients with unmet medical needs in select specialty and rare disease...
Geneve, Switzerland
AMO Pharma LTD
AMO Pharma is working to develop novel therapeutics for rare genetic neurodevelopmental di...
Durham, United States
Tokyo, Japan
Rival Readout
Competing with Jazz Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Sompharmaceuticals
Pioneering new therapies for rare endocrine and neuroendocrine tumors with unmet medical n...
Invitae
As a Labcorp company, we’re bringing comprehensive genetic information into mainstream med...
San Francisco, United Sta...
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Blueprint Medicines
Striving to improve and extend patients' lives
Cambridge, United States
Degron Therapeutics
Aims to become a global leader in the discovery and development of molecular glue degrader...
San Diego, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Vertex Pharmaceuticals
The Science of Possibility
Boston, United States
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
About Jazz Pharmaceuticals
Jazz Pharmaceuticals, founded in 2003, is a global biopharmaceutical company headquartered in Ireland. The company is committed to transforming the lives of patients by developing life-changing medicines for serious diseases, especially those with limited treatment options. With a significant corporate presence in the...
life-changing medicines development, clinical trial management, patient support programs, corporate partnerships development, medical education and fellowships
patients with rare diseases, healthcare professionals, biopharmaceutical investors, pharmaceutical partners, caregivers and families affected by rare diseases
Biopharmaceutical, Neurology, Psychiatry, Rare Diseases, Innovation, Sleep Disorders, Oncology, Hematology, Metabolic Diseases, Extended-release Formulations, Selective Serotonin Reuptake Inhibitors, Corporate Culture, Unmet Medical Needs
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Jazz Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Jazz Pharmaceuticals on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
